Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans.
Haefely
W E
WE
Pharmaceutical Research Department, F. Hoffmann-La Roche Ltd, Basle, Switzerland.
Kettler
R
R
Keller
H H
HH
Da Prada
M
M
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000037:antagonists & inhibitors; D000818:Animals; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007527:Isoenzymes / Q000502:physiology*; D008099:Liver / Q000201:enzymology; D051379:Mice; D008995:Monoamine Oxidase / Q000502:physiology*; D008996:Monoamine Oxidase Inhibitors; D010848:Picolinic Acids / Q000494:pharmacology*; D051381:Rats; D012642:Selegiline / Q000494:pharmacology
D007527:Isoenzymes; D008996:Monoamine Oxidase Inhibitors; D010848:Picolinic Acids; D012642:Selegiline; C059303:lazabemide; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D008995:Monoamine Oxidase